Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#111 / 200 Total
AMRC - Ameresco Inc. - Stock Price Chart
TickerAMRC [NYSE, RUT]
CompanyAmeresco Inc.
CountryUSA
IndustryEngineering & Construction
Market Cap1.09BEPS (ttm)1.17
P/E17.81EPS this Y7.67%
Forward P/E11.04EPS next Y39.50%
PEG0.65EPS past 5Y7.63%
P/S0.79EPS next 5Y27.20%
P/B1.21EPS Q/Q88.88%
Dividend-Sales Q/Q33.05%
Insider Own39.10%Inst Own62.12%
Insider Trans0.44%Inst Trans-0.38%
Short Float15.63%EarningsMay 07/a
Analyst Recom1.62Target Price35.50
Avg Volume541.90K52W Range17.55 - 63.19
Ameresco, Inc. engages in the provision of energy services, including energy efficiency, infrastructure upgrades, asset sustainability, and renewable energy solutions for businesses and organizations throughout North America and Europe. It operates through the following segments: U.S. Regions, U.S. Federal, Canada, Non-Solar Distributed Generation (DG), and All Other. The U.S. Regions, U.S. Federal, and Canada segments offer energy efficiency products and services, such as design, engineering and installation of equipment and other measures to improve the efficiency and control the operation of a facility's energy infrastructure, and renewable energy solutions and services. The Non-Solar DG sells electricity, processed renewable gas fuel, heat or cooling, produced from renewable sources of energy, other than solar, and generated by small-scale plants, and operations and maintenance services for customer owned small-scale plants. The All Other segment focuses on the provision of enterprise energy management services, consulting services, and integrated-photovoltaic. The company was founded by George Peter Sakellaris on April 25, 2000 and is headquartered in Framingham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patton Charles R.DirectorApr 20 '24Option Exercise0.004410441Apr 22 05:43 PM
Sutton Joseph W.DirectorApr 01 '24Option Exercise6.7010,00067,00022,163Apr 02 08:10 PM
Christakis PeterExecutive Vice PresidentMar 19 '24Sale20.531082,21711,370Mar 19 06:40 PM
Bakas Michael TExecutive Vice PresidentMar 19 '24Sale20.531082,21710,748Mar 19 06:40 PM
Hole Spencer DoranEVP and CFOMar 19 '24Sale20.531082,2171,878Mar 19 06:42 PM
ESPR - Esperion Therapeutics Inc. - Stock Price Chart
TickerESPR [NASD]
CompanyEsperion Therapeutics Inc.
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap356.18MEPS (ttm)-2.11
P/E-EPS this Y80.92%
Forward P/E39.72EPS next Y113.58%
PEG-EPS past 5Y23.09%
P/S3.06EPS next 5Y16.90%
P/B-EPS Q/Q33.60%
Dividend-Sales Q/Q71.38%
Insider Own1.10%Inst Own48.28%
Insider Trans0.00%Inst Trans5.01%
Short Float11.82%EarningsMay 07/b
Analyst Recom1.75Target Price7.41
Avg Volume6.26M52W Range0.70 - 3.40
Today 08:00AM Esperion to Report First Quarter 2024 Financial Results on May 7 (GlobeNewswire) +9.42%
Apr-21-24 10:39AM 11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Apr-07-24 02:45PM Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity (GlobeNewswire)
Apr-01-24 08:00AM Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024 (GlobeNewswire)
Mar-28-24 11:30AM Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report? (Zacks)
Mar-26-24 08:00AM Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-25-24 04:00PM Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24 (GlobeNewswire) +14.41%
Mar-22-24 06:26PM U.S. FDA Approves Broad New Labels for Esperion's NEXLETOL and NEXLIZET to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use (Business Wire) +8.53%
03:10PM U.S. FDA Approves Broad New Labels for NEXLETOL and NEXLIZET to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use (GlobeNewswire)
11:04AM CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events (GlobeNewswire)
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Warren EricChief Commercial OfficerSep 20 '23Sale1.2574292468,318Sep 21 05:06 PM
Warren EricChief Commercial OfficerAug 18 '23Sale1.4124334469,060Aug 21 04:32 PM
Warren EricChief Commercial OfficerJul 19 '23Sale1.5810616869,303Jul 20 04:38 PM
Warren EricChief Commercial OfficerJun 21 '23Sale1.4860389469,409Jun 22 04:45 PM
Warren EricChief Commercial OfficerMay 17 '23Sale1.6221935670,012May 18 04:07 PM
VCSA - Vacasa Inc - Stock Price Chart
TickerVCSA [NASD]
CompanyVacasa Inc
CountryUSA
IndustrySoftware - Application
Market Cap91.56MEPS (ttm)-24.07
P/E-EPS this Y83.93%
Forward P/E-EPS next Y42.52%
PEG-EPS past 5Y-
P/S0.08EPS next 5Y-2.96%
P/B0.62EPS Q/Q75.19%
Dividend-Sales Q/Q-18.66%
Insider Own51.41%Inst Own20.68%
Insider Trans-7.93%Inst Trans198.54%
Short Float11.19%EarningsFeb 28/a
Analyst Recom2.75Target Price9.50
Avg Volume74.85K52W Range5.62 - 17.80
Vacasa, Inc. engages in the provision of a vertically integrated vacation rental management platform. The firm is also involved in supplying the short-term rental market and in a growing homeowner base. The company was founded on July 1, 2021 and is headquartered in Portland, OR.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mossytree Inc.10% OwnerFeb 16 '24Sale9.1912,500114,935287,505Feb 20 10:41 AM
Mossytree Inc.10% OwnerFeb 15 '24Sale8.52412,5003,515,800300,005Feb 20 10:41 AM
Mossytree Inc.10% OwnerFeb 14 '24Sale9.2412,500115,451712,505Feb 14 08:02 PM
Mossytree Inc.10% OwnerFeb 13 '24Sale9.0811,507104,507725,005Feb 14 08:02 PM
Mossytree Inc.10% OwnerFeb 12 '24Option Exercise0.00550,0000736,512Feb 14 08:02 PM
MCHX - Marchex Inc - Stock Price Chart
TickerMCHX [NASD]
CompanyMarchex Inc
CountryUSA
IndustryAdvertising Agencies
Market Cap58.72MEPS (ttm)-0.23
P/E-EPS this Y75.00%
Forward P/E67.25EPS next Y166.67%
PEG-EPS past 5Y-29.80%
P/S1.18EPS next 5Y15.00%
P/B1.60EPS Q/Q67.98%
Dividend-Sales Q/Q0.84%
Insider Own18.79%Inst Own59.65%
Insider Trans0.33%Inst Trans-1.59%
Short Float0.38%EarningsMar 14/a
Analyst Recom1.00Target Price3.00
Avg Volume74.19K52W Range1.11 - 2.20
Marchex, Inc. operates as a conversational analytics and solutions company which helps businesses connect, drive, measure, convert callers into customers, and connects the voice of the customer to business. It offers Marchex call analytics platform, Marchex call marketplace and Marchex local leads products to automotive, travel and hospitality, telecommunications, insurance, home services, digital agencies, healthcare, education & careers, financial services, legal, real estate and senior living industries. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support its customers across voice and text-based communication channels. The company was founded by Russell C. Horowitz, Ethan A. Caldwell, Peter Christothoulou, and John Keister on January 17, 2003 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Edenbrook Capital, LLC10% OwnerNov 10 '23Buy1.4115,20021,37413,239,567Nov 13 05:04 PM
Edenbrook Capital, LLC10% OwnerNov 09 '23Buy1.3911,77516,34013,224,367Nov 13 05:04 PM
MDIA - MediaCo Holding Inc - Stock Price Chart
TickerMDIA [NASD]
CompanyMediaCo Holding Inc
CountryUSA
IndustryBroadcasting
Market Cap51.76MEPS (ttm)-0.40
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.60EPS next 5Y-
P/B1.39EPS Q/Q36.96%
Dividend-Sales Q/Q-44.79%
Insider Own88.15%Inst Own1.86%
Insider Trans0.00%Inst Trans137.85%
Short Float0.07%Earnings-
Analyst Recom-Target Price-
Avg Volume4.07M52W Range0.40 - 6.86
Mediaco Holding, Inc. is a radio broadcasting media company. Its purpose is to acquire and operates radio stations and its associated assets located in New York. The firm operates through Radio and Outdoor Advertising segments. The company was founded in June 2019 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EMMIS CORPDirectorJun 14 '23Sale1.3912,91317,949362,099Jun 16 04:00 PM
EMMIS CORPDirectorJun 13 '23Sale1.5033,25849,887375,012Jun 14 04:00 PM
EMMIS CORPDirectorJun 12 '23Sale1.271,0261,303408,270Jun 14 04:00 PM
EMMIS CORPDirectorJun 07 '23Sale1.286988409,296Jun 08 04:00 PM
EMMIS CORPDirectorJun 06 '23Sale1.27400508409,365Jun 08 04:00 PM
CODA - Coda Octopus Group Inc. - Stock Price Chart
TickerCODA [NASD]
CompanyCoda Octopus Group Inc.
CountryUSA
IndustryAerospace & Defense
Market Cap73.28MEPS (ttm)0.21
P/E31.52EPS this Y-3.57%
Forward P/E14.91EPS next Y62.96%
PEG-EPS past 5Y-11.00%
P/S4.02EPS next 5Y-
P/B1.46EPS Q/Q-54.48%
Dividend-Sales Q/Q-20.28%
Insider Own50.59%Inst Own20.05%
Insider Trans0.00%Inst Trans2.19%
Short Float2.38%EarningsMar 18/b
Analyst Recom1.00Target Price7.50
Avg Volume29.03K52W Range5.21 - 11.09
Coda Octopus Group, Inc. engages in the developing, manufacturing, and marketing of subsea products. It operates through the Marine Technology Business (Products) and Marine Engineering Business (Services) segments. The Marine Technology Business segment develops solutions for subsea and underwater markets. The Marine Engineering Business segment supplies engineering services primarily to prime defense contractors. It also operates through the Americas, Europe, Australia or Asia, and Middle East or Africa geographical segments. The company was founded in 1994 and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gayle AnnmarieChairman, CEOOct 06 '23Buy5.9916,50098,77695,038Oct 10 04:05 PM
Sondergaard Niels10% OwnerOct 06 '23Buy5.9916,50098,77633,080Oct 10 04:05 PM
Sondergaard Niels10% OwnerSep 28 '23Buy6.0316,58099,97716,580Sep 29 04:05 PM
Gayle AnnmarieChairman, CEOSep 28 '23Buy6.0316,58099,97778,538Sep 29 04:05 PM
RUNNELS G TYLERDirectorSep 28 '23Sale6.03105,006633,186609,331Sep 29 04:05 PM
POAI - Predictive Oncology Inc - Stock Price Chart
TickerPOAI [NASD]
CompanyPredictive Oncology Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap5.24MEPS (ttm)-3.48
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y53.33%
P/S2.94EPS next 5Y-
P/B0.63EPS Q/Q57.45%
Dividend-Sales Q/Q-7.82%
Insider Own3.72%Inst Own9.04%
Insider Trans0.00%Inst Trans-16.15%
Short Float0.65%EarningsMar 28/a
Analyst Recom1.00Target Price100.00
Avg Volume28.53K52W Range1.12 - 7.12
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment is composed of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nuzum Charles Lee SrDirectorSep 25 '23Sale3.0410,00030,38724,033Sep 27 05:03 PM
UXIN - Uxin Ltd ADR - Stock Price Chart
TickerUXIN [NASD]
CompanyUxin Ltd ADR
CountryChina
IndustryAuto & Truck Dealerships
Market Cap311.75MEPS (ttm)-41.30
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y31.20%
P/S1.51EPS next 5Y-
P/B-EPS Q/Q-158.53%
Dividend-Sales Q/Q-45.58%
Insider Own2.10%Inst Own0.02%
Insider Trans0.00%Inst Trans-46.45%
Short Float0.05%EarningsApr 25/b
Analyst Recom1.00Target Price640.42
Avg Volume58.00K52W Range1.50 - 18.90
Uxin Ltd. engages in the operation of an online used car transaction services platform. The company was founded by Dai Kun on August 11, 2011 and is headquartered in Beijing, China.
EBON - Ebang International Holdings Inc - Stock Price Chart
TickerEBON [NASD]
CompanyEbang International Holdings Inc
CountryChina
IndustryComputer Hardware
Market Cap52.19MEPS (ttm)-6.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S4.60EPS next 5Y-
P/B0.16EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own23.81%Inst Own6.38%
Insider Trans0.00%Inst Trans-2.94%
Short Float1.17%Earnings-
Analyst Recom-Target Price-
Avg Volume42.26K52W Range5.41 - 18.94
Ebang International Holdings, Inc. is a blockchain technology company, which engages in the research and development of ASIC chip technology used in blockchain applications in China. It also manufactures bitcoin mining machines. The company was founded by Dong Hu in January 2010 and is headquartered in Hangzhou, China.
ALAB - Astera Labs Inc. - Stock Price Chart
TickerALAB [NASD]
CompanyAstera Labs Inc.
CountryUSA
IndustrySemiconductors
Market Cap10.94BEPS (ttm)-0.17
P/E-EPS this Y339.48%
Forward P/E140.09EPS next Y94.35%
PEG-EPS past 5Y-
P/S94.46EPS next 5Y-
P/B-EPS Q/Q171.24%
Dividend-Sales Q/Q148.17%
Insider Own32.01%Inst Own7.64%
Insider Trans0.08%Inst Trans-
Short Float3.07%EarningsMay 07/a
Analyst Recom1.27Target Price86.09
Avg Volume3.81M52W Range50.61 - 95.21
Astera Labs, Inc. manufactures semiconductors. It offers smart retimers, riser cards, and GPU booster cards. The company products include: Aries PCIe CXLSmart DSP Retimers, Taurus Ethernet Smart Cable Modules and Leo CXL Memory Connectivity Controllers. Astera Labs is founded by Jitendra Mohan, Casey Morrison and Sanjay Gajendra in October 2017 and headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HURLSTON MICHAEL E.DirectorMar 22 '24Buy36.0021,747782,892121,747Mar 22 04:47 PM
LAZAR JACK RDirectorMar 22 '24Buy36.0010,000360,000165,000Mar 22 05:06 PM
ALBA MANUELDirectorMar 22 '24Buy36.005,000180,0005,000Mar 22 04:46 PM
1789101112131415161720